Evidence map›Paper›PMID 28559206›Full record

Trial reportBiological psychology2017

Working hard for oneself or others: Effects of oxytocin on reward motivation in social anxiety disorder.

Angela Fang, Michael T Treadway, Stefan G Hofmann

Registry-linked trialOpen access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Biological psychology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01856530 (Effect of Oxytocin on Pro-Social Behavior in Social Anxiety Disorder), which is not on this map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01856530 phase1 / phase2completednot on this map

Effect of Oxytocin on Pro-Social Behavior in Social Anxiety Disorder

TypeinterventionalSponsorStefan G. HofmannRan2012 to 2013Enrolled60ConditionsSocial Anxiety DisorderArmsOxytocin, Placebo
3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 29 citations in OpenAlex.

  1. Social anxiety and the positive valence system: A scoping review.Journal of mood and anxiety disorders · 2026
    Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Molecular and neurocircuitry mechanisms of social avoidance.Cellular and molecular life sciences : CMLS · 2021
    Review
  9. Review
  10. The Role of Intranasal Oxytocin in Anxiety and Depressive Disorders: A Systematic Review of Randomized Controlled Trials.Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Angela FangMassachusetts General Hospital/Harvard Medical School, Boston, MA, United States. Electronic address: afang@mgh.harvard.edu.
Michael T TreadwayEmory University, Atlanta, GA, United States.
Stefan G HofmannBoston University, Boston, MA, United States.
Boston University · USEmory University · USHarvard University · US

Funding

Toward Outcome Measurement of Anxiety in Youth with Autism Spectrum DisordersR01MH099021 · NIMH · YALE UNIVERSITY · PI SCAHILL, LAWRENCE D. · 2012 to 2015
$2.7M
1/2-Yoga For Generalized Anxiety DisorderR01AT007257 · NCCIH · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI HOFMANN, STEFAN G. · 2013 to 2017
$2.0M
Brain Correlates of Self-Focused Processing as a Biomarker of Treatment ResponseK23MH109593 · NIMH · UNIVERSITY OF WASHINGTON · PI FANG, ANGELA · 2016 to 2020
$888k
Neural Dimensions of Attention Bias Modification for Transdiagnostic AnxietyK23MH100259 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI PRICE, REBECCA · 2013 to 2017
$788k
2/3-Dose Timing of D-cycloserine to Augment CBT for Social Anxiety DisorderR34MH099311 · NIMH · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI HOFMANN, STEFAN G. · 2014 to 2016
$737k
Stress and MDD effects on mPFC Glutamate and GABA during reward processingR00MH102355 · NIMH · EMORY UNIVERSITY · PI TREADWAY, MICHAEL TILGHMAN · 2015 to 2017
$733k
Exposure Therapy for Fear of Falling in Older AdultsR34MH086668 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI WETHERELL, JULIE L · 2010 to 2012
$691k
Fear extinction memory in primary insomniaR21MH101567 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI PACE-SCHOTT, EDWARD F. · 2014 to 2015
$464k
Improving Therapeutic Learning in Depression: Proof of ConceptR21MH102646 · NIMH · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI OTTO, MICHAEL W. · 2014 to 2015
$452k
NCCIH NIH HHS R01 AT007257NIMH NIH HHS K23 MH100259NIMH NIH HHS K23 MH109593NIMH NIH HHS R00 MH102355NIMH NIH HHS R01 MH099021NIMH NIH HHS R21 MH101567NIMH NIH HHS R21 MH102646NIMH NIH HHS R34 MH086668NIMH NIH HHS R34 MH099311
6 · The paper itself

Abstract

There is some evidence to suggest that oxytocin promotes social behavior, especially for disorders characterized by social dysfunction, such as social anxiety disorder (SAD). The goal of this study was to examine the effect of oxytocin on reward motivation in SAD. We tested whether oxytocin promotes prosocial, or antisocial, self-directed decisions, and whether its effects depended on social anxiety severity and attachment. Fifty-two males with SAD received 24 international units of oxytocin or placebo, and completed a reward motivation task that measured willingness to work for self vs. other monetary rewards. Although there was no main drug effect, social anxiety severity moderated the effect of oxytocin. Less socially anxious individuals who received oxytocin worked harder for other vs. own rewards, compared to high socially anxious individuals. Attachment did not moderate this effect. Among people with SAD, oxytocin enhances prosocial behaviors in individuals with relatively lower levels of social anxiety. National Institutes of Health ClinicalTrials.gov Registry #NCT01856530. https://clinicaltrials.gov/ct2/show/NCT01856530?term=oxytocin+pro-social&rank=2.

Indexed as

Object AttachmentRewardAdultHumansMaleMotivationOxytocinPhobia, SocialSocial BehaviorTreatment OutcomeYoung AdultOxytocinMotivationOtherOxytocinRewardSelf

Identifiers

PMID28559206
PMCPMC5949234
OpenAlexW2618659627

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.